RESEARCH COOPERATION. WIPO and ECCAS may take the appropriate measures to conduct research and studies on innovation and disseminate practical information on best practices and technical know-how necessary for fostering development in science, technology, commerce and culture in ECCAS Member States.
RESEARCH COOPERATION. 5.1 PURAC shall report to BF semi-annually, with the next report due three (3) months following the Effective Date, on the status of its development efforts, including the progress made in the development effort since the last report and any problems or challenges encountered in developing Licensed Products.
5.2 BE shall, upon request and subject to negotiation of a separate consulting agreement containing mutually acceptable terms, provide PURAC with a limited number of days of consulting services from its consultant. Xxxxxx Xxxxxx, Ph.D., which services shall be directed towards providing PURAC with advice and assistance as PURAC may request regarding the research and development activities pursuant to this Agreement.
RESEARCH COOPERATION. During the Research Term, North Shore will share with CTI data North Shore generates pursuant to the Research Plan on a timely basis and North Shore and CTI will discuss and mutually agree upon priorities, future research to be conducted, and any changes to the Research Plan.
RESEARCH COOPERATION. WIPO and WAEMU may take the appropriate measures to conduct research and studies on innovation and disseminate practical information on best practices and technical know-how necessary for fostering development in science, technology, commerce and culture in WAEMU Member States.
RESEARCH COOPERATION. 17.1 Know-how transfer. GEAC agrees that GEAC will provide CVUT with necessary know- how, human resources and cooperation for their further development and use according to the Scope of Work and the terms of this Agreement.
RESEARCH COOPERATION. 6.1. The Parties may collaborate and enter into a research partnership, upon such terms as shall be mutually agreed between the Party REDACTED Parties in good faith.
RESEARCH COOPERATION. 8.1 Consistent with the existing research cooperation between Schering and AgrEvo, a research cooperation between Schering and the Company shall be established which -- subject to pre-existing contractual obligations vis-a- vis third parties or one of the Parties -- shall provide for a mutual exchange of compounds, libraries and screening possibilities (together the "Compounds"). It is the understanding of the Parties that Schering shall grant to the Company the right of testing the Compounds of Schering and its controlled entities (the "Schering Compounds") for a period of 15 (fifteen) months beginning with the receipt of the Compounds. This also includes the right for the Company to provide the respective legal entities owning the animal health and nutrition businesses of the Aventis group and the Hoechst group (together, the "Aventis Animal Health Businesses") with the Schering Compounds. After expiration of this period, the Company shall have a period of 60 (sixty) days to exercise its rights for an exclusive, worldwide, irrevocable license with the right to sublicense to Affiliates for Schering Compounds in the fields of business of the Company and the Aventis Animal Health Businesses.
8.2 The Parties further agree that the respective legal entity(ies) owning the human pharma business of the Aventis group and the Hoechst group (together, the "Aventis Pharma Business") shall have a right of first testing the Compounds of the Company and its controlled entities (the "Company's Compounds") for a limited period of 9 (nine) months beginning with the receipt of the Company's Compounds. After expiration of this period, the Aventis Pharma Business shall have a period of 60 (sixty) days to exercise its rights for an exclusive, worldwide, irrevocable license with a right to sublicense to Affiliates for the Company's Compounds in the human pharmaceutical business.
8.3 With regard to all the Company's Compounds for which this right is not exercised within the above mentioned 60 (sixty) day period, the Company is obliged to grant to Schering the right of testing the Company's Compounds for its human pharmaceutical business for a limited period of 15 (fifteen) months beginning with the receipt of the Compounds. After expiration of this period, Schering shall have a period of 60 (sixty) days to exercise its rights for an exclusive, worldwide, irrevocable license with the right to sublicense to Affiliates for the Company's Compounds in Schering's human pharmaceutical...
RESEARCH COOPERATION. Research cooperation is possible in the form of joint applications for financing the research, joint conducting research, research-related visits in partner institutions, joint publications, conferences, etc. A separate agreement stipulating terms and conditions of research cooperation shall be reached.
RESEARCH COOPERATION. The information provided on contract research also applies to joint results achieved from research cooperation. If, by contrast, this involves results achieved by the indus- try partner or results achieved by the university/research institute, there is no need to issue a separate regulation. However, the group of experts thinks that a separate reg- ulation would need to be issued in respect of joint results if the project manager and other employees of a univer- sity/research institute have a share in the invention that is far lower than 50 percent. If its share in the invention is less than 20 percent, the university/research institute shall desist from participating in the patent application. In this case, the university/research institute has no vested interest in attaining visibility. Contract research (assignment) The applicant status is designed in Clause 9 as a trustee relationship. This highlights the fact that the industry part- ner has substantive rights even though the application is being filed on behalf of the university/research insti- tute (cf. the relevant variant under Clause 8) and also on behalf of the industry partner, as a joint patent applica- tion. In order to pre-empt any disputes between the par- ties, Xxxxxx 9 also stipulates that the initial priority appli- cation must be a German or European patent application. The contracting parties can of course make other arrange- ments. As far as announcing its share in the invention is concerned, the university/research shall be sufficiently pro- tected if it is recognised as a co-applicant within the first 18 months provided the application is filed and published on its behalf. The contractual modules make provision for the rights to be assigned to the industry partner which shall terminate the trustee relationship. Contract research (license) N. B.: from this regulation onwards, the numbering of the types of agreement will also differ, since there is no need to regulate the applicant status in respect of the licence var- iant. This regulation needs to be issued by the university/ research institute.
RESEARCH COOPERATION. 3.1 Both institutions will search for possibilities of research cooperation in the areas of their mutual interest. These areas primarily include issues of development studies, sustainable development, geoinformatics, human and physical geography, religious studies and social and cultural anthropology.
3.2 They agree to discuss possibilities to submit projects applicable to various funding schemes of the European Union (esp. Erasmus+), while allowing for other options as well.
